Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female rat.
about
G protein-coupled receptors: extranuclear mediators for the non-genomic actions of steroidsHeart Disease in Women: Unappreciated Challenges, GPER as a New TargetType-2 pericytes participate in normal and tumoral angiogenesisG-protein-coupled estrogen receptor as a new therapeutic target for treating coronary artery diseaseThe G-protein-coupled estrogen receptor GPER in health and diseaseRole of estrogen in diastolic dysfunctionEstrogen-mediated renoprotection following cardiac arrest and cardiopulmonary resuscitation is robust to GPR30 gene deletionGPER/GPR30 and Regulation of Vascular Tone and Blood Pressure.Interfering with mineralocorticoid receptor activation: the past, present, and futureEvidence that the G protein-coupled membrane receptor GPR30 contributes to the cardiovascular actions of estrogen.Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstrictionMinireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiologyImprovement of vascular function by acute and chronic treatment with the GPR30 agonist G1 in experimental diabetes mellitus.What have we learned about GPER function in physiology and disease from knockout mice?Estrogen receptor subtypes mediate distinct microvascular dilation and reduction in [Ca2+]I in mesenteric microvessels of female rat.Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activationEstrogen receptor GPR30 reduces oxidative stress and proteinuria in the salt-sensitive female mRen2.Lewis ratThe G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function.Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivityInternational Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic ModulatorsPregnancy Augments G Protein Estrogen Receptor (GPER) Induced Vasodilation in Rat Uterine Arteries via the Nitric Oxide - cGMP Signaling PathwayActivation of G protein-coupled estrogen receptor 1 (GPER-1) decreases fluid intake in female ratsThe effects of (-)-epicatechin on endothelial cells involve the G protein-coupled estrogen receptor (GPER).Long- but not short-term estradiol treatment induces renal damage in midlife ovariectomized Long-Evans rats.Adaptive increases in expression and vasodilator activity of estrogen receptor subtypes in a blood vessel-specific pattern during pregnancy.The putative G-protein coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian and breast cancer cells in a GPER-independent manner.Endogenous estrogen attenuates hypoxia-induced pulmonary hypertension by inhibiting pulmonary arterial vasoconstriction and pulmonary arterial smooth muscle cells proliferation.Subtype-specific estrogen receptor-mediated vasodilator activity in the cephalic, thoracic, and abdominal vasculature of female rat.Transforming growth factor β1 antagonizes the transcription, expression and vascular signaling of guanylyl cyclase/natriuretic peptide receptor A - role of δEF1.Reduced vasorelaxation to estradiol and G-1 in aged female and adult male rats is associated with GPR30 downregulation.Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo.The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System.GPER-novel membrane oestrogen receptor.G protein-coupled estrogen receptor agonist improves cerebral microvascular function after hypoxia/reoxygenation injury in male and female rats.Vasodilation by GPER in mesenteric arteries involves both endothelial nitric oxide and smooth muscle cAMP signaling.Hormonal effects on blood vessels.Estrogen and the cardiovascular system.Vascular effects of aldosterone: sorting out the receptors and the ligands.Identification and characterization of new mechanisms in vascular oestrogen signalling.Membrane estrogen receptors: their role in blood pressure regulation and cardiovascular disease.
P2860
Q22305605-B41D580D-B68F-40DC-8B64-362AE49951B1Q26746957-79C5D7BC-33FE-4A01-BFA9-3F79A2E2FCAFQ26782015-4D889336-6F1B-44C0-BC4B-59DCDE1FEC7CQ27001986-9CF9FF9D-2735-4A7D-85E5-08C5F1B69784Q27013052-D95A428B-C010-4C88-8D45-7D332DF85F4DQ27026798-66669CCA-83AE-409B-AC1F-B78B9354F8CCQ33748878-87CF4862-30ED-4535-A28C-7DB1F7C484E1Q33835934-A722D452-F6A9-499A-851C-D592C04EB5B9Q34019947-D89272A8-05C2-46AC-8BC3-170C40D75E32Q34239340-651D4A20-6D73-4E14-85A0-53D0D4D2F1E1Q34243343-900483B0-5600-433C-B7F1-094A6F8CEEA3Q34267558-26B990B1-369F-4B3B-82D4-7585A2A93F37Q34297149-E8CBE2F8-C75A-4C63-AEEE-676EBEB86DD0Q34485765-B1BC815C-BFE7-4264-8F7F-962FDDD598B2Q34946607-44CB68AD-B056-40BF-BF75-87438D5156FBQ35135440-71374485-8384-435B-90FF-C788881D084BQ35216117-1D56A1FB-8991-435F-8CA0-DC60D46DC686Q35551803-79AFC1DB-1BB6-44E9-A307-87FB1F41CEC0Q35563456-E5FA0626-B1E8-482F-8D1A-0E3036239AF5Q35795751-46782866-BA25-4655-9601-C7AE007D9F55Q35832036-001D1929-9116-4D9C-84F9-512B4E52B3BAQ35988611-DDE8F2D7-05EF-4C6C-B7E2-0F31CD90C1B8Q36014772-BB22F26E-4657-4D2C-B162-FAA3662AD850Q36268401-AADBF6DC-C8E7-4E86-B69A-8AA689E1D18BQ36339474-9A269F22-09F3-47A0-A993-2044D271B40BQ36383070-32DE2F9A-350F-426F-8CF1-2F1B41D4B8D0Q36800936-8BD8AFF4-17E1-4E04-9635-AC8C90553D28Q36876332-20486B7B-FFCE-409C-995E-35FE84C8E1D0Q36967309-C79AE0CF-B9D5-4EC1-B0CD-FB187895111BQ37051112-6FA8EE17-E098-4EB3-9AE3-04DA71C3CAA3Q37174747-1503FE7C-0407-4692-844E-131ACF9F2E01Q37234859-6735E3BF-322D-4A9F-844E-6C58116A9B5EQ37444596-1EB077B2-214E-469B-93E1-2BC0CB30061AQ37581966-90608A52-CA5A-4789-ACF7-05D820F76182Q37627060-28C6F650-9EB5-49E2-8312-FEB6892E0BD8Q37980611-5B52A684-459A-48B1-A153-5B55AE86E78BQ38000962-E5DD9A40-E512-418D-8164-FCDF5A294E89Q38125527-62ABAD81-6BA8-44E0-A398-6BE8EED16A95Q38129555-A8C65231-6112-4397-AA44-1C738CF87298Q38171692-E711FFE8-B7A0-40F9-B6E6-9F141D3C525F
P2860
Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female rat.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Vasodilation in response to th ...... in the mRen2.Lewis female rat.
@ast
Vasodilation in response to th ...... in the mRen2.Lewis female rat.
@en
Vasodilation in response to th ...... in the mRen2.Lewis female rat.
@nl
type
label
Vasodilation in response to th ...... in the mRen2.Lewis female rat.
@ast
Vasodilation in response to th ...... in the mRen2.Lewis female rat.
@en
Vasodilation in response to th ...... in the mRen2.Lewis female rat.
@nl
prefLabel
Vasodilation in response to th ...... in the mRen2.Lewis female rat.
@ast
Vasodilation in response to th ...... in the mRen2.Lewis female rat.
@en
Vasodilation in response to th ...... in the mRen2.Lewis female rat.
@nl
P2093
P2860
P1476
Vasodilation in response to th ...... in the mRen2.Lewis female rat.
@en
P2093
Eric R Prossnitz
Kyle A Carver
Mark C Chappell
Sarah H Lindsey
P2860
P304
P356
10.1097/FJC.0B013E3182135F1C
P407
P577
2011-05-01T00:00:00Z